Searched for
CARDIOVASCULAR AND RENAL TREATMENT
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Future diabetes care seen leaning towards GLP-1 drugsThe diabetes treatment landscape in India is on the brink of transformation. Innovative GLP-1 medications are set to redefine therapy stand...
Roche to acquire liver drug developer 89bio for up to $3.5 billionRoche is set to acquire 89bio for up to $3.5 billion, gaining access to the promising liver disease drug pegozafermin. This move complement...
Lupin acquires UK-based firm for 12.3 million poundsLupin has acquired UK-based Renascience Pharma for £12.3 million, enhancing its branded medicine portfolio. The acquisition allows Lupin to...
Diabetes, heart, and kidneys: The hidden links you can’t afford to ignoreDiabetes impacts not just blood sugar but also the heart and kidneys. High sugar levels strain these organs, causing complications. Regular...
Sun Pharma inks pact with Bayer to sell drug for chronic kidney diseaseSun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights...
Glenmark launches antidiabetic drug in IndiaThe drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the compan...
How to keep your kidneys healthy? Here are some valuable Ayurveda tipsAyurveda offers natural and safe tips for keeping kidneys healthy and rejuvenated, including staying hydrated by consuming 1.5 liters of wa...
Fabry disease: Advocacy group seeks Health Ministry's interventionPatients of Fabry disease in India are calling for equal recognition under the National Policy for Rare Diseases 2021. Advocacy group, Lyso...
Proper hydration may extend your lifespan: StudyPeople who drink more water have lower chances to develope heart and lung disease.
Boehringer Ingelheim India seeks system to keep tab on patent infringementIn terms of focus areas in the country, she said the drug firm is focussed on providing solutions for non communicable diseases like diabet...
Experiencing sleep issues, muscle pain & fatigue? It could mean your kidneys are in dangerOn World Kidney Day, here are the warning signs you must watch out for and tips to reverse them.
Astrazeneca gets marketing authorisation to use anti-diabetes drug for kidney diseaseThe drug is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment...
Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...
Decoded: Why COVID-19 is more severe in older people than youngThis study reported more severe disease outcomes in patients with hypertension.
Want to keep your kidney safe? Consume less saltKidney failure is among the top five major causes of death in India.
- Gujarat government rolls out healthcare scheme for poor
Gujarat government has rolled out healthcare and health insurance schemes for 1.8 crore poor who can be treated free for critical diseases.
- Syria facing severe shortage of medicines and medical supplies: World Health Organisation
The civil war in Syria has lead to a severe shortage of essential medicines and pharmaceutical products in the country, according to a late...